A Phase 2 Study of Verubulin With Radiation Therapy and Temozolomide in Subjects Newly Diagnosed With Glioblastoma Multiforme.

Trial Profile

A Phase 2 Study of Verubulin With Radiation Therapy and Temozolomide in Subjects Newly Diagnosed With Glioblastoma Multiforme.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 25 Apr 2015

At a glance

  • Drugs Temozolomide; Verubulin
  • Indications Glioblastoma
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 25 Apr 2015 Results of incomplete analysis presented at the 67th Annual Meeting of the American Academy of Neurology.
    • 08 Sep 2011 Status changed from recruiting to discontinued, as reported in a Myrexis media release.
    • 22 Dec 2010 Status changed from planning to recruiting according to a Myrexis media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top